EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Danshen (Salvia miltiorrhiza) extract in spinal cord injury (SCI): a systematic review and meta-analysis

Yuanna Zhang, Dongping Wan, Rui Tang, Rui Wang, Haodong Wu, Feilong Li, Xiang Ji, Xi Gao, Shihang Cao

Frontiers in Pharmacology · 20.04.2026 · 17

DOI: 10.3389/fphar.2026.1754584 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.04.2026. Verfasst von Yuanna Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aims to systematically assess the effectiveness of Danshen ( Salvia miltiorrhiza ) extract in animal models of spinal cord injury (SCI) and provide high-quality evidence to support the translation from preclinical research to clinical practice.

Methods

A systematic review and meta-analysis of 35 randomized controlled trials involving animal models of SCI were conducted. Data were extracted regarding the effects of Danshen extract on motor function (measured by the BBB score), inflammation, oxidative stress, apoptosis, and edema. Subgroup analyses based on model type, drug dosage, and compound type were also performed.

Results

Danshen extract significantly improved motor function at multiple time points (3, 7, 14, and 21 days post-injury). The BBB scores were higher in the treatment group across all time points (SMD = 4.53 at 3 days, p < 0.001). Additionally, Danshen reduced inflammatory markers (TNF-α, IL-1β), oxidative stress (MDA), and apoptotic markers (Caspase-3), while increasing antioxidant activity (SOD). It also significantly reduced spinal cord edema, as indicated by decreased water content in the injury areas (SMD = −3.88, p < 0.00001). Subgroup analysis showed the most significant improvements in contusion and ischemic models, with higher doses (>20 mg/kg) and water-soluble phenolic acids providing the best outcomes.

Conclusion

Danshen extract exhibits significant potential in treating SCI through its diverse mechanisms, such as reducing inflammation, combating oxidative stress, preventing cell death, and alleviating edema. However, further research is needed to refine treatment protocols and establish its clinical relevance. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/recorddashboard .

Schlagwörter

Stichwörter der Autor:innen

DanshenDanshen extractSalvia miltiorrhizameta-analysisspinal cord injury

Autor:innen und Institutionen

  • Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
  • The First Clinical Medical College, Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region, China.
  • The Clinical Medical College, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.
  • Department of Orthopedics and Traumatology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan Province, China.

Zitieren

APA

Zhang, Y., Wan, D., Tang, R., Wang, R., Wu, H., Li, F., Ji, X., Gao, X., & Cao, S. (2026). Danshen (Salvia miltiorrhiza) extract in spinal cord injury (SCI): a systematic review and meta-analysis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1754584

Vancouver

Zhang Y, Wan D, Tang R, Wang R, Wu H, Li F, et al. Danshen (Salvia miltiorrhiza) extract in spinal cord injury (SCI): a systematic review and meta-analysis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1754584

BibTeX
@article{Zhang2026,
  author = {Zhang, Yuanna and Wan, Dongping and Tang, Rui and Wang, Rui and Wu, Haodong and Li, Feilong and Ji, Xiang and Gao, Xi and Cao, Shihang},
  title = {Danshen (Salvia miltiorrhiza) extract in spinal cord injury (SCI): a systematic review and meta-analysis},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1754584}
}
Kostenlos starten →